Lumenis Launches Stellar M22 Platform Featuring XPL Technology
The latest iteration of the multi-application platform adds new pulsed-light features and is approved to treat over 30 indications for skin and hair removal.
The latest iteration of the multi-application platform adds new pulsed-light features and is approved to treat over 30 indications for skin and hair removal.
The latest version features increased energy output, interchangeable spot sizes, and system upgrades aimed at enhancing multi-modal aesthetic treatments.
The move brings Xeomin and Radiesse to China as part of the company’s broader international expansion.